J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shefer, S.
Right arrow Articles by Tint, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shefer, S.
Right arrow Articles by Tint, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 33, 1193-1200, Copyright © 1992 by Lipid Research, Inc.


ARTICLES

Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat

S Shefer, LB Nguyen, G Salen, GC Ness, IR Chowdhary, S Lerner, AK Batta and GS Tint
Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103.

We investigated the effects of cholesterol, cholestyramine, and taurocholate feeding on steady state specific activities and mRNA levels of hepatic 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase and cholesterol 7 alpha-hydroxylase in the rat. Interruption of the enterohepatic circulation of bile acids (cholestyramine feeding) increased total HMG-CoA reductase activity 5-fold. Cholesterol and taurocholate administration suppressed total microsomal HMG-CoA reductase activities 87% and 65%, respectively. HMG-CoA reductase mRNA levels increased 3-fold with cholestyramine, did not decrease significantly with cholesterol feeding, but were markedly decreased after taurocholate treatment. Cholesterol 7 alpha-hydroxylase activity increased 4-fold with cholestyramine and 29% during cholesterol feeding, but decreased 64% with taurocholate. Cholesterol 7 alpha- hydroxylase mRNA levels rose 150% and 50% with cholestyramine and cholesterol feeding, respectively, but decreased 73% with taurocholate. The administration of cholesterol together with taurocholate prevented the decline in cholesterol 7 alpha-hydroxylase mRNA levels, but inhibition of enzyme activity persisted (-76%). Hepatic microsomal cholesterol concentrations increased 2-fold with cholesterol feeding but did not change with taurocholate or cholestyramine treatment. These results demonstrate that mRNA levels of HMG-CoA reductase are controlled by the hepatic taurocholate flux, whereas mRNA levels of cholesterol 7 alpha-hydroxylase are controlled by the cholesterol substrate supply. These end products, cholesterol and bile acids, exert post-transcriptional regulation on HMG-CoA reductase and cholesterol 7 alpha-hydroxylase, respectively.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Q. Shang, L. Pan, M. Saumoy, J. Y. L. Chiang, G. S. Tint, G. Salen, and G. Xu
An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXR{alpha}
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G817 - G823.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Q. Shang, L. Pan, M. Saumoy, J. Y. L. Chiang, G. S. Tint, G. Salen, and G. Xu
The stimulatory effect of LXR{alpha} is blocked by SHP despite the presence of a LXR{alpha} binding site in the rabbit CYP7A1 promoter
J. Lipid Res., May 1, 2006; 47(5): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. T. Cramer, B. Goetz, K. L. M. Hopson, G. J. Fici, R. M. Ackermann, S. C. Brown, C. L. Bisgaier, W. G. Rajeswaran, D. C. Oniciu, and M. E. Pape
Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome
J. Lipid Res., July 1, 2004; 45(7): 1289 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Xu, L.-x. Pan, H. Li, Q. Shang, A. Honda, S. Shefer, J. Bollineni, Y. Matsuzaki, G. S. Tint, and G. Salen
Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G730 - G735.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Xu, H. Li, L.-x. Pan, Q. Shang, A. Honda, M. Ananthanarayanan, S. K. Erickson, B. L. Shneider, S. Shefer, J. Bollineni, et al.
FXR-mediated down-regulation of CYP7A1 dominates LXR{alpha} in long-term cholesterol-fed NZW rabbits
J. Lipid Res., October 1, 2003; 44(10): 1956 - 1962.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. A. Davis, J. H. Miyake, T. Y. Hui, and N. J. Spann
Regulation of cholesterol-7{alpha}-hydroxylase: BAREly missing a SHP
J. Lipid Res., April 1, 2002; 43(4): 533 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Xu, G. Salen, B. L. Shneider, M. Ananthanarayanan, S. Shefer, L. Ma, A. Batta, L. B. Nguyen, J. J. Lingutla, G. S. Tint, et al.
Cholecystectomy prevents expansion of the bile acid pool and inhibition of cholesterol 7{alpha}-hydroxylase in rabbits fed cholesterol
J. Lipid Res., September 1, 2001; 42(9): 1438 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness and C. M. Chambers
Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: The Concept of Cholesterol Buffering Capacity
Experimental Biology and Medicine, May 1, 2000; 224(1): 8 - 19.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
G. Xu, B. L. Shneider, S. Shefer, L. B. Nguyen, A. K. Batta, G. S. Tint, M. Arrese, S. Thevananther, L. Ma, S. Stengelin, et al.
Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits
J. Lipid Res., February 1, 2000; 41(2): 298 - 304.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
A. Honda, G. Salen, S. Shefer, A. K. Batta, M. Honda, G. Xu, G. S. Tint, Y. Matsuzaki, J. Shoda, and N. Tanaka
Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7{alpha}-hydroxylase and 27-hydroxylase activities in rat liver
J. Lipid Res., August 1, 1999; 40(8): 1520 - 1528.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
M. L. Fernandez, T. A. Wilson, K. Conde, M. Vergara-Jimenez, and R. J. Nicolosi
Hamsters and Guinea Pigs Differ in Their Plasma Lipoprotein Cholesterol Distribution when Fed Diets Varying in Animal Protein, Soluble Fiber, or Cholesterol Content
J. Nutr., July 1, 1999; 129(7): 1323 - 1332.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
G. Xu, G. Salen, S. Shefer, G. S. Tint, L. B. Nguyen, T. T. Parker, T. S. Chen, J. Roberts, X. Kong, and D. Greenblatt
Regulation of classic and alternative bile acid synthesis in hypercholesterolemic rabbits: effects of cholesterol feeding and bile acid depletion
J. Lipid Res., August 1, 1998; 39(8): 1608 - 1615.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
K. K. Buhman, E. J. Furumoto, S. S. Donkin, and J. A. Story
Dietary Psyllium Increases Fecal Bile Acid Excretion, Total Steroid Excretion and Bile Acid Biosynthesis in Rats
J. Nutr., July 1, 1998; 128(7): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. V. Rodrigueza, K. D. Mazany, A. D. Essenburg, M. E. Pape, T. J. Rea, C. L. Bisgaier, and K. J. Williams
Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2132 - 2139.
[Abstract] [Full Text]


Home page
NEJMHome page
G S. Tint, M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen
Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz Syndrome
N. Engl. J. Med., January 13, 1994; 330(2): 107 - 113.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. M. Baker, S.-L. Wang, D. J. Bell, C. A. Drevon, and R. A. Davis
One or More Labile Proteins Regulate the Stability of Chimeric mRNAs Containing the 3'-Untranslated Region of Cholesterol-7alpha -hydroxylase mRNA
J. Biol. Chem., June 23, 2000; 275(26): 19985 - 19991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1992 by the American Society for Biochemistry and Molecular Biology.